Trial Profile
Nebivolol in Chronic Obstructive Pulmonary Disease
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II/III
Latest Information Update: 29 Jan 2016
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 11 Jan 2016 Status changed from recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov.
- 15 Sep 2013 New trial record